iGenetic Diagnostics

What iGenetic Diagnostics does

iGenetic Diagnostics is a Mumbai-based, privately held diagnostics laboratory founded in 2013 that operates across the full spectrum of pathology, from routine biochemistry and immunology testing through to specialized genomic diagnostics. The company's service portfolio targets oncology testing, rare disease diagnosis, reproductive genomics, and preventive health screening, serving a customer base composed of hospitals, diagnostic networks, and individual patients across India. Per-test pricing falls within the Indian genomic testing range of ₹20,000 to ₹1,00,000 per test, indicating a positioning weighted toward higher-value specialized assays rather than commodity routine work, though routine pathology services anchor volume.

The business model is a service-based diagnostic testing revenue model, monetizing through per-test fees paid by healthcare providers and patients, with no disclosed subscription, capitated, or value-based pricing structures. The company has raised approximately $20.5 million in total disclosed funding across two rounds — a $1 million early-stage round in January 2016 and a $19.5 million round in February 2017 led by British International Investment, a development finance institution. The company is led by founder and Managing Director Arunima Patel alongside co-founders Homer Paneri and Siddharth Patodia. The company operates within India's broader $8 billion pathology market (fragmented across 150,000+ labs) and the $270 million DNA sequencing market projected to reach $1.4 billion by 2030 at a 27% CAGR. Source material does not disclose specific product architecture, lab automation stack, proprietary technology platforms, certifications, partnerships, named hospital customers, or financial performance metrics.

Name

iGenetic Diagnostics

Website

https://igenetic.com

Company type

Private

Founded year

2013

Headcount range

1–10 employees

Short description

iGenetic Diagnostics is a Mumbai-based diagnostics laboratory founded in 2013 offering routine pathology (biochemistry, immunology) and specialized genomic testing across oncology, rare disease, reproductive genomics, and preventive health for hospitals, diagnostic networks, and patients in India.

Ownership category

akta.pro rank

Product category

Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

akta.pro secondary industries

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Clinical Chemistry & Immunoassay Laboratories (HLAFAMAB)

Keywords

• Diagnostic laboratory services
• Pathology testing services
• Genomic testing solutions
• Molecular diagnostics
• Clinical pathology

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Core offering

iGenetic Diagnostics operates a comprehensive diagnostics laboratory offering routine pathology tests in Biochemistry and Immunology alongside advanced genomic and molecular testing for oncology, rare diseases, reproductive genomics, and preventive health screening. Services are delivered to hospitals, diagnostic networks, and individual patients across India at per-test price points of ₹20,000 to ₹1 lakh.

Differentiator

Problem solved

Functional benefit

Products and services

• Routine Pathology Testing (Biochemistry and Immunology)
• Genomic and Molecular Diagnostics

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators4 records

Recent moves3 records

Expansion highlights3 records

Direct peers

• Strand Life Sciences: Strand Life Sciences is an Indian genomics-driven diagnostics and bioinformatics company providing genetic testing, molecular diagnostics, and clinical genomics solutions. It directly competes with iGenetic in oncology and rare disease genomic testing across hospital networks.
• Mapmygenome: Mapmygenome is an Indian personal genomics and preventive health testing company offering genetic tests for disease risk, wellness, and pharmacogenomics. It overlaps with iGenetic's preventive health screening and reproductive genomics use cases.
• MedGenome: MedGenome is a leading Indian genomics and molecular diagnostics company offering genetic testing across oncology, reproductive health, and rare diseases. It is the most direct competitor to iGenetic, operating in the same genomic testing segments with similar hospital and patient channels.

Broad incumbents

• Thyrocare Technologies: Thyrocare Technologies is an Indian diagnostics company known for affordable, high-volume preventive and routine testing, now expanding into specialized diagnostics. It competes with iGenetic through cost-effective routine pathology and emerging specialty offerings.
• Metropolis Healthcare: Metropolis Healthcare is a leading Indian diagnostics chain with a comprehensive portfolio spanning routine pathology to molecular diagnostics. It is a broad incumbent competing with iGenetic across both routine and specialty testing segments.
• Dr. Lal PathLabs: Dr. Lal PathLabs is India's largest diagnostic chain by network and revenue, now expanding into molecular and genetic testing. As a broad incumbent, it competes with iGenetic in routine pathology while increasingly encroaching on advanced genomic testing.
• SRL Diagnostics: SRL Diagnostics is one of India's largest diagnostic service networks, offering routine and advanced pathology including molecular diagnostics. As a broad incumbent with hospital partnerships, it competes with iGenetic across multiple testing segments.
• Apollo Diagnostics: Apollo Diagnostics is the diagnostic arm of Apollo Hospitals, offering comprehensive pathology services including advanced and molecular testing. It leverages the Apollo hospital network for patient referrals, competing directly with iGenetic in both routine and genomic testing.
• Manipal TRUtest: Manipal TRUtest is a chain of complete diagnostic services in India offering CT, MRI, routine blood tests, and specialized diagnostics. It is a broad incumbent with a comparable service portfolio to iGenetic's routine and specialized testing mix.

Emerging players

• 4baseCare: 4baseCare is an Indian precision oncology company specializing in genomic profiling for cancer treatment. It is an emerging player in the oncology genomics segment that iGenetic also serves, competing for hospital and oncologist referrals.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/igeneticdiagnostics
• LinkedInlinkedin.com/company/igenetic-diagnostics-pvt-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about iGenetic Diagnostics